Features of systemic cytokine production in Behcet's disease associated with uveitis without ocular lesions

Autor: E. S. Sorozhkina, G. I. Krichevskaya, N. V. Balatskaya, I. G. Kulikova, A. E. Andryushin, G. A. Davidova, T. A. Lisitsyna

Publikováno v: Медицинская иммунология, Vol 23, Iss 5, Pp 1079-1088 (2021)

Behcet's disease (BD) is a systemic disease underlyed by chronic vasculitis. Hyperactivity of innate and adaptive immunity plays important role in its pathogenesis. Uveitis occurs in 30-70% of the patients, often recurring and reducing visual functio

Externí odkaz: https://doaj.org/article/346b27f772f74459b1116a403ac0b3b6

Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials

Autor: Alexandra P. Song, Nobuhisa Mizuki, Anne Camez, Antoine P. Brézin, Nisha V. Kwatra, Masanori Miyazaki, Noritaka Inomata, Andrew D. Dick, Quan Dong Nguyen, Noriyasu Hashida, Toshikatsu Kaburaki, Martina Kron, Masahiro Zako, Glenn J. Jaffe, Koju Kamoi, Hiroshi Goto, Samir R. Tari, Koh Hei Sonoda, Toshiaki Abe, Shigeaki Ohno, Kenichi Namba

Publikováno v: Goto, H, Zako, M, Namba, K, Hashida, N, Kaburaki, T, Miyazaki, M, Sonoda, K H, Abe, T, Mizuki, N, Kamoi, K, Brézin, A P, Dick, A D, Jaffe, G J, Nguyen, Q D, Inomata, N, Kwatra, N V, Camez, A, Song, A P, Kron, M, Tari, S & Ohno, S 2018, ' Adalimumab in Active and Inactive, Non-Infectious Uveitis : Global Results from the VISUAL I and VISUAL II Trials ', Ocular Immunology and Inflammation . https://doi.org/10.1080/09273948.2018.1491605

PURPOSE: Report global adalimumab safety and efficacy outcomes in patients with non-infectious uveitis.METHODS: Adults with non-infectious intermediate, posterior, or panuveitis were randomized 1:1 to receive placebo or adalimumab in the VISUAL I (ac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a12c9d9b4c8176e6ed9def9ce50501
https://doi.org/10.1080/09273948.2018.1491605

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.